RxDoctor Payments Data

Grace Tang, MD

Family Medicine · Wake Forest, NCNPI 1932243227

Payments from drug & device makers

$428in general payments, 2019–2025

Across 23 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$151
  • Pfizer$66
  • Irhythm Technologies, Inc.$53
  • Lilly USA, LLC$52
  • Novo Nordisk$48
  • Baxter Healthcare$18
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$428100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$428 in reported general payments places this provider in the 55th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$73,195
Medicare patients
255
Services billed
894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide57$68,711
EliquisApixaban54$47,069
RybelsusSemaglutide36$41,293
MounjaroTirzepatide39$37,945
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$31,983
JardianceEmpagliflozin16$24,560
JanuviaSitagliptin Phosphate25$14,538
XareltoRivaroxaban14$7,877
Breo ElliptaFluticasone/Vilanterol11$4,406
SynthroidLevothyroxine Sodium57$4,139
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$3,264
Levothyroxine Sodium247$2,873
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$2,821
Atorvastatin Calcium279$2,660
Rosuvastatin Calcium291$2,592

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$48$110,00593 claims
PfizerEliquis$66$47,06954 claims
Lilly USA, LLCMounjaro$52$37,94539 claims
GSKTrelegy Ellipta, Breo Ellipta$14$36,38857 claims
MerckJanuvia$16$14,53825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Wake Forest

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →